These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7376686

  • 1. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P, Korn A, Hitzenberger G, Zazgornik J, Kopsa H, Pils P.
    Wien Med Wochenschr; 1980 Feb 29; 130(4):171-3. PubMed ID: 7376686
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics, tolerance and therapeutic effect of trimethoprim-sulfametrol-infusions (author's transl)].
    Breyer S, Graninger W, Hitzenberger G.
    Wien Med Wochenschr; 1980 Jun 30; 130(12):448-50. PubMed ID: 6999751
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of Lidaprim in cases of impaired renal function.
    Hitzenberger G, Korn A, Pichler H, Bonelli J, Magometschnigg D.
    Int J Clin Pharmacol Biopharm; 1977 Jul 30; 15(7):310-4. PubMed ID: 892947
    [Abstract] [Full Text] [Related]

  • 4. [Sulfametrol-trimethoprim in the treatment of chronic urinary tract infections].
    Pichler H, Kofler K, Ludvik W, Porpaczy P, Scherzer W.
    Acta Med Austriaca; 1975 Jul 30; 2(5):170-6. PubMed ID: 1220516
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R, Camez A, Veys N, Van Loo A, Dhondt AM, Ringoir S.
    Thromb Haemost; 1997 Apr 30; 77(4):650-5. PubMed ID: 9134637
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of the bronchitic syndrome (author's transl)].
    Danilewicz A, Kronberger O, Vogel D.
    Wien Klin Wochenschr; 1975 May 02; 87(9):313-5. PubMed ID: 1136518
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 02; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.
    Clin Pharmacol Ther; 2000 Sep 02; 68(3):238-49. PubMed ID: 11014405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
    Pappas P, Karavasilis V, Briasoulis E, Pavlidis N, Marselos M.
    Cancer Chemother Pharmacol; 2005 Oct 02; 56(4):358-60. PubMed ID: 15883819
    [Abstract] [Full Text] [Related]

  • 12. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov 02; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of subacute pelvic inflammatory diseases with the antibiotic compound sulfametrol-trimethroprim (author's transl)].
    Burmucic R, Zierler H, Steiner P.
    Wien Med Wochenschr; 1981 Sep 15; 131(17):431-4. PubMed ID: 7303713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L, Gorgia A, Marmy A, Tschopp JM.
    Nephrologie; 1980 Sep 15; 1(4):177-82. PubMed ID: 6895408
    [Abstract] [Full Text] [Related]

  • 16. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr 15; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 17. [An absence of interaction of sulfametrol-trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)].
    Kaspar L.
    Wien Klin Wochenschr; 1980 Apr 11; 92(8):276-9. PubMed ID: 6996341
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetic and chemical investigations in children after oral administration of lidaprim (author's transl)].
    Brandesky G, Takacs F.
    Wien Klin Wochenschr; 1975 Oct 03; 87(18):611-5. PubMed ID: 1220265
    [Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 03; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Isoniazid pharmacokinetics in patients in chronic renal failure.
    Gold CH, Buchanan N, Tringham V, Viljoen M, Strickwold B, Moodley GP.
    Clin Nephrol; 1976 Aug 03; 6(2):365-9. PubMed ID: 954244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.